Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4651–4700 of 33076
On January 27, 2025, Bank First Corporation (the “Company”) announced that its Senior Vice President of Operations, Kristeen Pelot, has resigned from her position at the Company and its wholly owned banking subsidiary, Bank First, N.A.
it was determined that Rick Dillon, Executive Vice President and Chief Financial Officer, will leave the Company, effective February 14, 2025.
Timothy Donovan, Executive Vice President, Chief Legal Officer and General Counsel, notified Vestis Corporation (the “ Company ”) of his retirement to be effective February 14, 2025.
Cassan Pancham, Executive Vice President and Business Group Executive, will retire from his position at the Corporation effective May 15, 2025.
On January 27, 2025, Paul Ney, the Chief Legal Officer and Corporate Secretary of Momentus Inc. (the “Company”), tendered his resignation from the Company, effective as of January 28, 2025, to join the Trump Administration and serve as the Deputy Counsel to the President for National Security Affairs and National Security Council Legal Advisor.
On January 27, 2025, the Company and Dr. Algranati entered into a Separation and General Release Agreement (the "Separation Agreement"), pursuant to which Dr. Algranati's employment with the Company will end on February 1, 2025 (the "Separation Date").
On January 28, 2025, Ronald E. Blaylock, a member of the board of directors (the “Board”) of CarMax, Inc. (the “Company”), informed the Company that he would not stand for reelection as a member of the Board at the Company’s 2025 annual meeting of shareholders.
Shailesh M. Kotwal will cease to serve as the Company’s Vice Chair, Payment Services, effective February 3, 2025.
Scott W. Wine notified the Board that he does not intend to stand for re-election to the Company’s Board of Directors following expiration of his current term at the Company’s 2025 Annual Meeting of Shareholders.
which reported the retirement of Matthew T. Farrell as President and Chief Executive Officer ("CEO") of the Company
In connection with and effective upon the closing of the Mergers, Deborah G. Adams, Tiffany Thom Cepak and Leldon E. Echols resigned as directors of the Manager.
In connection with and effective upon the closing of the Mergers, Deborah G. Adams, Tiffany Thom Cepak and Leldon E. Echols resigned as directors of the Manager.
In connection with and effective upon the closing of the Mergers, Deborah G. Adams, Tiffany Thom Cepak and Leldon E. Echols resigned as directors of the Manager.
Jeffrey J. Lyash, TVA's President and Chief Executive Officer (CEO), notified his executive leadership team, and the TVA Board of Directors, of his intention to retire no later than October 2, 2025.
Ms. Elizabeth Frank, notified the Company of her resignation from the position of Executive Vice President, Worldwide Programming and Chief Content Officer effective February 7, 2025.
On January 28, 2025, Benjamin G. Ruddy notified the Eagle Bancorp Montana, Inc. (the “Company”) Board of Directors (the “Board”) of his decision to resign, for personal reasons, from the Company’s Board and the Board of Directors of its wholly-owned subsidiary Opportunity Bank of Montana, effective immediately.
On January 30, 2025, Phillip Massie Price and the Company mutually agreed that Mr. Price shall step down as Interim Chief Financial Officer of the Company, effective as of March 1, 2025, in connection with the appointment of Mr. Kowalczyk as Chief Financial Officer and Chief Operating Officer.
On January 27, 2025, Tom Kelly, a member of the Board of Directors (the “Board”), notified The Scotts Miracle-Gro Company (the “Company”) of his resignation from the Board with his term ending January 31, 2025.
On January 28, 2025, Matthew Breslin, the Chief Revenue Officer of Upland Software, Inc. (the “Company”), informed the Company that he will resign effective February 7, 2025.
On January 29, 2025, David Dornan, Ph.D., Chief Scientific Officer of Elevation Oncology, Inc. (the “Company”), informed the Company that he is resigning to pursue another opportunity, effective February 17, 2025.
Mr. Brian Hahn, the Company’s Chief Financial Officer, notified the Company’s board of directors of his intent to cease his respective employment with the Company no later than March 31, 2025.
On January 27 and 28, 2025, each of Vijay Pande and Michael Altman, respectively, informed Nautilus Biotechnology, Inc. (the “Company”) that they will not stand for re-election to the Company’s board of directors at the Company’s 2025 annual meeting of stockholders.
On January 27 and 28, 2025, each of Vijay Pande and Michael Altman, respectively, informed Nautilus Biotechnology, Inc. (the “Company”) that they will not stand for re-election to the Company’s board of directors at the Company’s 2025 annual meeting of stockholders.
Mr. Williams will cease serving in his role as Group President effective February 3, 2025, and will remain with the Company as Senior Executive Advisor until November 2025.
Harry V. Barton, Jr., age 70, informed FHN that he will retire from the Board effective when directors are elected at the 2025 annual meeting of shareholders.
On January 27, 2025, Candace Matthews, a member of the Board of Directors of MillerKnoll, Inc. (the “Company”) advised the Board that she was resigning from the Board effective February 15, 2025.
Mr. Weiss will step down as Co-CEO of CIB effective immediately and will retire from the Company on June 1, 2025.
On January 24, 2025, Scott Belsky notified Adobe Inc. (the “Company” or “Adobe”) of his decision to resign as Chief Strategy Officer and Executive Vice President, Design & Emerging Products, effective March 15, 2025, to pursue another career opportunity.
On January 29, 2025, Mr. John C. Gordon, a member of the Board of Directors (the “Board”) of First US Bancshares, Inc. (the “Company”), notified the Company of his resignation as a director of the Company effective January 31, 2025.
On January 30, 2025, Methode Electronics, Inc. (“Methode” or the “Company”) announced that Andrea J. Barry, Chief Administrative Officer and Chief Human Resources Officer of the Company, will step down from those positions effective January 31, 2025.
On January 24, 2025, Mr. John Wilson resigned from the Board of Directors of Marker Therapeutics, Inc.
On January 27, 2025, Eric Speron resigned as a member of the Company’s Board of Directors and its Compensation Committee, effective as of January 31, 2025.
Troy W. Thacker notified the Company that he has made the decision not to stand for re-election at the 2025 Annual Meetings
Ms. Payne will serve in advisory capacity until June 30, 2025, after which she will leave the Company.
David V. Goeckeler will resign from his position as the Company’s Chief Executive Officer.
each of David V. Goeckeler, Thomas Caulfield and Miyuki Suzuki will resign from their positions as members of the Company’s board of directors
each of David V. Goeckeler, Thomas Caulfield and Miyuki Suzuki will resign from their positions as members of the Company’s board of directors
each of David V. Goeckeler, Thomas Caulfield and Miyuki Suzuki will resign from their positions as members of the Company’s board of directors
accepted the resignation of Teresa S. Weber, the Company’s Chief Executive Officer, from all positions she holds with the Company, including stepping down from the Board, effective as of February 1, 2025
On January 24, 2025, Yuan Yixuan provided notice to the board of directors (the “Board”) of Chenghe Acquisition II Co. (the “Company”) of her resignation from her positions as chief executive officer and member of the Board.
On January 27, 2025, Mr. Neil Hare provided notice of his resignation from the Board of Directors (the “Board”) of Longeveron Inc. (the “Company”) to be effective immediately.
David Meline, a member of the Board, notified the Company of his resignation from the Board, effective January 30, 2025
On January 30, 2025, the Federal Home Loan Bank of San Francisco (the “Bank”) and Alanna McCargo, the Bank’s President and Chief Executive Officer, mutually agreed to terms pursuant to which Ms. McCargo will depart the Bank as an employee, effective January 30, 2025
On January 28, 2025, Paul J. Hastings, Chair of the Board of Directors (the “Board”), and Andreas Wicki, a member of the Board, each notified the Board of Pacira BioSciences, Inc. (the “Company”) of his respective decision to resign as a member of the Board, in each case, effective immediately
On January 28, 2025, Paul J. Hastings, Chair of the Board of Directors (the “Board”), and Andreas Wicki, a member of the Board, each notified the Board of Pacira BioSciences, Inc. (the “Company”) of his respective decision to resign as a member of the Board, in each case, effective immediately
On January 25, 2025, Weiting (Cathy) Feng, a member of the Board and the Chief Financial Officer and Chief Operating Officer of the Company, tendered her resignation to the Company as a member of the Board
On January 28, 2025, Julie Richardson notified the board of directors (the “Board”) of Yext, Inc. (the “Company”) that, after nearly 10 years of service to the Company, she intended to resign as a member of the Board, effective at the conclusion of the Company's current fiscal year on January 31, 2025.
On January 24, 2025, Vir Biotechnology, Inc. (the “Company”) announced that Ann (Aine) M. Hanly, Ph.D., the Company’s Executive Vice President and Chief Technology Officer, will be leaving the Company on February 26, 2025.
On January 28, 2025, Mr. Mann resigned as a member of the Board.
Effective January 24, 2025, Joseph Zawadzki resigned as a member of the board of directors (the “Board”) of Collective Audience, Inc., a Delaware corporation (the “Company”) and as Chairman of the Board
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.